Abstract | BACKGROUND: METHODS: The Nordic JIA database prospectively included JIA patients followed for eight years with data on remission and joint damage. From this database, serum samples collected from 192 patients, at a median of four months after disease onset, were analysed for IgG anti-CII, IgM RF, IgA RF and IgG anti-CCP. Joint damage was assessed based on Juvenile Arthritis Damage Index for Articular damage (JADI-A), a validated clinical instrument for joint damage. RESULTS: Elevated serum levels of anti-CII occurred in 3.1%, IgM RF in 3.6%, IgA RF in 3.1% and anti-CCP in 2.6% of the patients. Occurrence of RF and anti-CCP did to some extent overlap, but rarely with anti-CII. The polyarticular and oligoarticular extended categories were overrepresented in patients with two or more autoantibodies. Anti-CII occurred in younger children, usually without overlap with the other autoantibodies and was associated with high levels of C-reactive protein (CRP) early in the disease course. All four autoantibodies were significantly associated with joint damage, but not with active disease at the eight-year follow up. CONCLUSIONS: Anti-CII, anti-CCP, IgA RF and IgM RF detected early in the disease course predicted joint damage when assessed after eight years of disease. The role of anti-CII in JIA should be further studied.
|
Authors | Lillemor Berntson, Ellen Nordal, Anders Fasth, Kristiina Aalto, Troels Herlin, Susan Nielsen, Marite Rygg, Marek Zak, Johan Rönnelid, Nordic Study Group of Pediatric Rheumatology (NoSPeR) |
Journal | Pediatric rheumatology online journal
(Pediatr Rheumatol Online J)
Vol. 12
Pg. 22
( 2014)
ISSN: 1546-0096 [Print] England |
PMID | 24944545
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Autoantibodies
- Biomarkers
- Collagen Type II
- Immunoglobulin A
- Immunoglobulin M
- Rheumatoid Factor
|
Topics |
- Adult
- Age of Onset
- Arthritis, Juvenile
(diagnosis, epidemiology, immunology)
- Arthritis, Rheumatoid
(diagnosis, epidemiology, immunology)
- Autoantibodies
(blood)
- Biomarkers
(blood)
- Child
- Collagen Type II
(immunology)
- Disease Progression
- Female
- Follow-Up Studies
- Humans
- Immunoglobulin A
(blood)
- Immunoglobulin M
(blood)
- Male
- Prognosis
- Rheumatoid Factor
(blood)
- Scandinavian and Nordic Countries
(epidemiology)
|